Page results
-
This information is for patients who are doing a breath test at home. It includes the risks, and explains how to prepare, complete and return the test, as well as what to expect after the test.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
File results
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments